Abstract: Recent study on nonketotic hyperglycinemia, an inborn error of glycine metabolism, is reviewed from clinical, metabolic, molecular, and neuropathological points of view. This disorder is caused by an inherited deficiency of the mitochondrial glycine cleavage system (GCS), which causes accumulation of glycine in such body fluids as plasma, cerebrospinal fluid, and urine. There are four disease types: neonatal, infantile, late-onset, and transient types. The genetic backgrounds of the neonatal and infantile types have been largely clarified by a comprehensive mutational screening of genes encoding three components of the GCS, while the molecular pathogenesis of the late-onset and transient types are largely unknown. In the central nervous system of vertebrates, the GCS has been identified in astrocytes and neural stem cells. The GCS in astrocytes is co-localized with N-methyl-D-aspartate receptors, and is thought to maintain the glycine level around the receptors, while the physiological and pathological roles of the GCS in neural stem cells remains to be elucidated.
Introduction.
Nonketotic hyperglycinemia (NKH), also termed as glycine encephalopathy, is an inborn error of glycine metabolism, which is characterized by various neurological symptoms and accumulation of a large amount of glycine in the body. 1),2) Glycine levels in cerebrospinal fluids (CSF) are elevated to a much greater extent than in the plasma; hence, the abnormally high value of the CSF/plasma glycine ratio, which is used as a biochemical marker of NKH. NKH is inherited as an autosomal recessive trait.
2) The incidence of NKH is estimated as approximately one in 250,000 births. The incidence is unusually high in the following countries: Finland (1/12,000 births), 3) British Colombia (1/63,000 births), 4) and Israel. 5)-7) Molecular cloning of the glycine cleavage system (GCS) genes has enabled us to diagnose many patients by mutational analysis, which reveals atypical clinical symptoms of NKH. In this review we summarize the advances in the study of NKH, especially focusing on the phenotypic heterogeneity of this disorder. Identification of the metabolic lesion for NKH. Glycine is a nonessential amino acid, which has many metabolic pathways, as shown in Fig. 1 . Glycine loading to NKH patients results in a higher peak of glycine and a delay in the return to the preloading level, indicating a block in the main route of glycine degradation. 8) The main route for glycine catabolism had been thought to be its conversion to serine by serine hydroxymethylase, followed by its conversion by serine dehydratase to pyruvate, which enters the tricarboxylic acid cycle. However, Tada et al. found that the activities of serine hydroxymethylase and serine dehydratase were normal in the liver of NKH patients. On the contrary, the mitochondrial glycine cleavage system (GCS, EC2.1.2.10) was found to be markedly diminished in the liver of the patients with NKH. 9) These findings indicate that GCS plays the major route of glycine degradation. Glycine cleavage system. The mechanism of glycine breakdown by the glycine cleavage system (GCS) has been studied by the research group of Motokawa and Kikuchi.
10) The GCS catalyzes the con- (Table I) . A deficiency of dihydrolipoamide dehydrogenase causes progressive neurological deterioration with lactic acidosis, but not hyperglycinemia. 11) In this review we will discuss three GCS specific components, P-, T-, and H-proteins that are encoded by different genes (Table I) . P-protein consists of 1,020 amino acids 12), 13) and is encoded by the glycine decarboxylase (GLDC) gene 14) on chromosome 9p24. 15) T-protein has 403 amino acids 16) and is encoded by the aminomethyltransferase (AMT) gene on chromosome 3q21. 17) H-protein consists of 173 amino acids 18) and is encoded by the glycine cleavage system H-protein (GCSH) gene on chromosome 16q24. 19) Clinical symptoms. NKH is classified into four types based on the onset of disease: neonatal, infantile, late-onset, and transient types. 1) Neonatal type. This is the most common subtype of NKH. Most patients are products of uncomplicated, fullterm pregnancies. Recent brain imaging studies have revealed that patients with NKH frequently have brain malformation such as hypogenesis or agenesis of the corpus callosum, gyral malformation, ventricular enlargement, and cerebellar hypoplasia. The clinical pictures of the three patients are described below. Patient 1. Pregnancy and delivery of patient 1 were uneventful. He had a normal neonatal period. He sat without support at 10 months, walked at 2 years, talked at 3 years, and he had bowel and bladder control at 4 years of age. He was evaluated at four years and found to have mild psychomotor delay, appendicular ataxia, and choreoathetoid movements. His plasma glycine was elevated at 1,100 µmol/L (normal 186-431 µmol/L) and CSF glycine was 55 µmol/L (normal 1-9.8 µmol/L); hence the CSF glycine/plasma glycine ratio was 0.05 (normal < 0.03). Analysis of urine organic acids was normal, and the patient was diagnosed as having atypical NKH. Apart from the mild delay he manifested no significant neurological problems except for frequent outbursts of aggressiveness between ages 5 and 12. He attended special education classes at school and graduated from high school. He worked for two years as a department store greeter. He never had a seizure. His EEG at of 21 years age old was normal.
Patient 2. Patient 2 was born after full term pregnancy with a birth weight of 2,900 g. He was hypotonic after birth without respiratory problems and developed seizures during the first week of life. He walked at 5 years, had bowel and bladder control at 8 years. He still has expressive language problems at the age of 21. Seizures were difficult to control initially but currently are fairly well controlled with valproate. Since age 12 he has occasionally exhibited uncontrolled aggressive behavior. He has severe mental retardation. Plasma glycine at age 15 years was elevated at 1,670 µM (normal 186-431 µM) and CSF glycine was 150 µM (normal 1-9.8 µM). The CSF glycine/plasma glycine ratio was thus 0.09. An EEG at 20 of age years showed moderate generalized slowing. MRI analysis revealed central volume loss with mildly prominent ventricles. He attended special education classes and graduated from high school. Patient 3. The mother described decreased fetal movements during pregnancy. His birth weight was 3,600 g. He had a normal neonatal period. At 6 months he was found to be mild hypotonia, and metabolic screening revealed persistent glycinuria. Plasma glycine was elevated to 637 µmol/L (normal 186-431 µmol/L) and CSF glycine was 36 µmol/L (normal 1-9.8 µ mol/L). The CSF glycine/plasma glycine ratio was thus 0.056 (normal < 0.03). Analysis of urine organic acids was normal, excluding a secondary ketotic hyperglycinemia. His development was mildly delayed with impaired expressive language (Verbal IQ 70, Performance IQ 59, Full Scale IQ 59). During childhood he was diagnosed as having attention deficit hyperactivity disorder. During adolescence he had outbursts of aggressiveness and sexual impulsivity. He attended special education classes at school, and is currently works.
The three patients had GLDC mutations, which showed 5-8% of residual GLDC activity in the in vitro expression analysis, 28) suggesting that slight higher percent of residual activity results in a marked difference in clinical symptoms between neonatal and infantile NKH. Late-onset type. Mild neurological symptoms develop in preschool, school, or in adolescence. 30 ), 31) Clinical presentations of late onset NKH are heterogeneous; two families had no seizures nor mental retardation, but progressive paraplegia and optic atrophy. 32 ), 33) Another family presented mental retardation and choreoathetosis. 34) Transient type. Several patients have been described with the peculiar phenotype of transient neonatal hyperglycinemia. 35 ),36) At presentation, the patients with transient NKH were clinically indistinguishable from patients with neonatal type, with elevated CSF glycine/plasma glycine ratios diagnostic of NKH and a burst-suppression pattern on EEG. By 2-8 weeks of age, their elevated plasma and CSF glycine levels returned to normal. Most patients showed normal psychomotor development while some had severe neurologic symptoms. 37) The etiology of transient NKH remains unknown. Genetic background of NKH. In patients with neonatal NKH, 3 and 10 mutations have been reported in the GLDC and AMT genes, respectively. The GLDC mutations include one missense mutation, 38),39) one micro-deletion, 40) and one large deletion, 14) while the AMT mutations consist of eight missense mutations, 5),39),41)- 44) one micro-deletion, 42) and one splicing mutation. 39) Two AMT mutations, R320H and IVS7-1G > A, and one GLDC mutation, R515S, have been found to account for 5-7% of Caucasian mutant alleles, 43) whereas each of the other mutations have been detected in only a single family. Mutational analysis was performed in one family with infantile type, which revealed that the patient was a compound heterozygote of the AMT mutations, G47R and R320H.
41)
Recently, we have undertaken comprehensive mutational screening of the GLDC, AMT, and GCSH genes in 55 patients with the neonatal type of NKH, 5 patients with infantile type, and 8 patients with the late-onset type (Table II) . 45) No mutation has been identified in the eight patients with late-onset NKH, suggesting that it may be caused by mutations in genes other than the GCS genes. To elucidate the genetic background of transient Diagnosis. NKH should be considered when neonates or infants develop seizures, muscular hypotonia, and lethargy that are not readily explicable on the basis of infection, trauma, hypoxia, or other commonly encountered pediatric problems. Differential diagnosis between NKH and other diseases with hyperglycinemia is sometimes difficult. The absence of ketoacidosis is indicated by plasma biocarbonate levels and/or blood pH. Exclusion of organic acidemia by gas chromatographic analysis of urine or plasma are crucial. 47) In NKH the glycine level in CSF is elevated and the ratio of CSF to plasma glycine concentration is increased more than 0.09, while in normal and ketotic hyperglycinemia it is below 0.04. 26) An EEG finding of a burst suppression pattern is characteristic for NKH in the first month of life. There is a special demand for prenatal diagnosis, since no effective treatment has been established for NKH to date. We examined the GCS activity in tissues from an aborted fetus at risk for NKH. Activity of the GCS in liver, brain, and placenta were extremely low in the fetus as compared to controls, suggesting the feasibility of antenatal enzymatic diagnosis of NKH using chorionic villi tissues obtained by biopsy. 48 ),49) A number of fetuses at risk has been diagnosed by this method.
50)-52)
Prenatal DNA diagnosis is also possible if the causative mutation is identified.
52)
Neuropathogenesis of NKH. Glycine plays two distinct functions in the central nervous system. In the brain stem and spinal cord, glycine is an inhibitory neurotransmitter, 53) while, in the cerebral cortex, hippocampus, and cerebellum, glycine is an excitatory co-agonist of the N-ethyl-D-aspartate(NMDA)-type glutamate receptor-channel complex. It has been reported that the specific activity of GCS is high in the telencephalon and low in the spinal cord in the central nervous system of the adult rat. 54) The authors also reported an inverse relationship between the GCS activity and glycine content in various regions of the rat brain. In immunohistochemical and in situ hybridization studies of P-protein, astrocytes in the telencephalon and cerebellum were strongly labeled, while the labeling of the spinal cord and brain stem was faint. 55),56) These data suggest the GCS may make little contribution to inhibitory glycine transmission, but modulate NMDA-mediated responses by removal of excessive synaptic glycine in adult rat brain as illustrated in Fig. 4 . Neuroradiological examinations have revealed frequent association of brain malformation in patients with NKH 20) but the neuropathogenesis of prenatal brain damage in NKH remains unclear. We identified the functional GCS in embryonic neuroepithelial stem cells and neural stem cells prepared by neurosphere culture.
57)
The GCS in neural stem cells may play a role distinct from that in adult astrocytes. Congenital malformations reported in NKH are parenchymal volume loss, thin corpus callosum (including agenesis), gyral malformation, ventricular enlargement, and cerebellar hypoplasia. 20) These hypoplastic abnormalities suggest the deterioration of cellular proliferation in prenatal NKH brains.
Recently, it has been demonstrated that folate deficiency affects the proliferation of neural stem cells. 58) The GCS provides one carbon unit (C 1 ), which is used for folate metabolism. Brain malformation associated with NKH may be attributed to impaired folate metabolism caused by GCS deficiency.
